SMITH ASSET MANAGEMENT GROUP LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$72,000
-8.9%
6300.0%0.00%
-33.3%
Q1 2019$79,000
-77.0%
630
-75.1%
0.00%
-75.0%
Q4 2018$343,000
-52.5%
2,530
-3.8%
0.01%
-42.9%
Q3 2018$722,000
+64.5%
2,630
+24.1%
0.02%
+61.5%
Q2 2018$439,000
+25.4%
2,1200.0%0.01%
+8.3%
Q1 2018$350,000
-34.8%
2,120
-45.9%
0.01%
-29.4%
Q4 2017$537,000
+0.6%
3,9200.0%0.02%
-5.6%
Q3 2017$534,000
+12.2%
3,9200.0%0.02%
+20.0%
Q2 2017$476,000
+14.7%
3,9200.0%0.02%
+25.0%
Q1 2017$415,000
+4.0%
3,920
-0.3%
0.01%0.0%
Q4 2016$399,000
-0.5%
3,9300.0%0.01%0.0%
Q3 2016$401,000
-1.7%
3,930
+14.9%
0.01%0.0%
Q2 2016$408,000
+7.9%
3,420
-3.1%
0.01%
+9.1%
Q1 2016$378,000
-60.0%
3,530
-82.5%
0.01%
-68.6%
Q3 2014$945,000
-24.9%
20,119
-0.3%
0.04%
-23.9%
Q2 2014$1,258,000
-10.8%
20,189
-3.7%
0.05%
-14.8%
Q1 2014$1,411,000
+26.9%
20,970
-0.8%
0.05%
+28.6%
Q4 2013$1,112,00021,1350.04%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders